Immunotherapy Center is a center of research excellence at Georgia University of Medical Sciences. Many diseases develop
, because the immune system more active, and in autoimmune diseases (eg, type of diabetes, rheumatoid arthritis, multiple sclerosis
, lupus, etc.), or in-active as cancer and chronic infectious diseases ( such as HIV, hepatitis, tuberculosis, Listeria,
, etc.). P primary role of the immune system is to eliminate microbial infections that cause pathogenic disease. P
To fulfill this key function of immune cells to recognize and respond to foreign molecules (antigens) expressed by invading pathogens
leads to the destruction of pathogenic microorganisms and cells they infect. P the ability of immune cells to recognize the huge range of different antigens
explains why transplanted organs between people are not accepted if immunosuppressive agents are
patients to suppress graft rejection. P autoimmune diseases occur because the immune system is not regulated properly
and immune cells begin to destroy healthy cells and tissues, such as cells produce insulin, leading to type 1 diabetes. P
In addition, more active immune cells contribute to inflammatory processes that lead to cardiovascular disease over time. Unlike PP >> <<, diseases like cancer and chronic infections occur, particularly because the immune system is suppressed wrong
leads to a state special access, which allows tumors to grow and infection persists in People with otherwise effective
immune system. P Mission Statement GHSU immunotherapy is to identify fundamental molecular and cellular mechanisms >> << processes that control the immune system and to translate this new knowledge into innovative approaches to prevention and treatment
clinical disease. P To achieve this, scientists using mobile systems and animal models of working with clinical researchers
and clinical departments to improve understanding of immune system function and apply this knowledge to treat disease in the clinic >>. P << In recognition of the important role of the immune system in the etiology of cancer immunotherapy has moved to center
new Center for Cancer Research in 2006, which features new research institutions to support basic and clinical research
including new facilities to help patients research material for preclinical studies and clinical trials of experimental >>. Studies << Immunotherapy Center focuses on the fundamental mechanisms governing the immune system that help
prevent autoimmune disease, but allow tumors and chronic infections remain. P Research Aims to find out how
manipulate these mechanisms to stimulate the immune system to attack tumor and infected cells, and to prevent the immune system >> << destroying healthy cells and transplanted organs and tissues. PP Director of
candidate and Deputy Director
MD, lead study groups to study how cells that express indoleamine 2,3 dioxygenase (IDO) suppress immune responses, mechanisms
first discovered in GHSU in 1998. From the doctor. Mallory and Mann continues to describe a new understanding of this mechanism, providing new opportunities
to treat patients. P supported by the National Cancer Institute (NIH) and corporate partners, experimental
clinical trial to see if pharmacologic inhibition of IDO improve the treatment of cancer and chronic infections are lasix online currently in progress
. P plans to conduct further tests on patients attending clinics GHSU Cancer also well developed. P
candidate leads the research group to study regulatory T cells that inhibit the immune response mediation of other T cells. A P
basic research, these researchers are discovering new ways to manipulate T cells, to improve disease outcomes in the clinic >>. << P
candidate is studying the role of B cells in autoimmune disease and protective vaccination following memory. PP
Ph.D. His research interests focus mainly on systemic autoimmune diseases and development of mechanisms for inflammatory diseases
manifestation / progression to end-stage organ failure goal. P
MD, Ph D is interested in how tumors avoid the natural immunity during neoplasia. P For this group it is focusing on
, cells in tumor lesions, which promote immune against the rules. P Santhakumar Manicassamy, Ph.D. examines the major mechanisms
regulating the immune response by adoptive]]] mucoscal surface of the gastrointestinal track. New data from research by Dr. Manicassamys shed light on the interaction between microorganisms and kommensalnyh how interaction can be
functional dysfunction causing an increased risk of inflammatory bowel disease and colon cancer. P
Immunotherapy GHSU Center under the direction of Dr. Mallory and Mann, who founded the center in 2002. P As the director of immunotherapy
Center, Dr. Mallory report Dean, Faculty of Medicine and is responsible for the overall development of research programs
and administration. R In addition to its core research activities, Dr. Mann is responsible for the development of clinical research
Program Cancer Center and lead GHSU Cancer program in immunotherapy of cancer. P immunotherapy Business Center Manager
is Ms. Phyllis Mack, Administrative Assistant Mrs. Tracy West and Office Specialist is Ms. Natasha Alford. . << >>
No comments:
Post a Comment